These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2114618)

  • 1. Pulmonary delivery of peptide drugs: effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers.
    Adjei A; Garren J
    Pharm Res; 1990 Jun; 7(6):565-9. PubMed ID: 2114618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans.
    Adjei A; Sundberg D; Miller J; Chun A
    Pharm Res; 1992 Feb; 9(2):244-9. PubMed ID: 1553349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal absorption of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: absorption by various routes and absorption enhancement.
    Okada H; Yamazaki I; Ogawa Y; Hirai S; Yashiki T; Mima H
    J Pharm Sci; 1982 Dec; 71(12):1367-71. PubMed ID: 6818337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hetero-stereocomplexes of D-poly(lactic acid) and the LHRH analogue leuprolide. Application in controlled release.
    Slager J; Domb AJ
    Eur J Pharm Biopharm; 2004 Nov; 58(3):461-9. PubMed ID: 15451519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.
    Okada H; Heya T; Ogawa Y; Shimamoto T
    J Pharmacol Exp Ther; 1988 Feb; 244(2):744-50. PubMed ID: 3126294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report.
    Cassidenti DL; Sauer MV; Paulson RJ; Ditkoff EC; Rivier J; Yen SS; Lobo RA
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1806-10. PubMed ID: 1750479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of formulation adjuvants on gastrointestinal absorption of leuprolide acetate.
    Adjei A; Love S; Johnson E; Diaz G; Greer J; Haviv F; Bush E
    J Drug Target; 1993; 1(3):251-8. PubMed ID: 8069567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals.
    Ogawa Y; Okada H; Heya T; Shimamoto T
    J Pharm Pharmacol; 1989 Jul; 41(7):439-44. PubMed ID: 2570847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats. IV: Evaluation of the vaginal absorption and gonadotropin responses by radioimmunoassay.
    Okada H; Yamazaki I; Yashiki T; Shimamoto T; Mima H
    J Pharm Sci; 1984 Mar; 73(3):298-302. PubMed ID: 6425491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation.
    Fluker M; Grifo J; Leader A; Levy M; Meldrum D; Muasher SJ; Rinehart J; Rosenwaks Z; Scott RT; Schoolcraft W; Shapiro DB;
    Fertil Steril; 2001 Jan; 75(1):38-45. PubMed ID: 11163814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of using ganirelix acetate versus a 4-day follicular phase leuprolide acetate protocol in unselected women undergoing in vitro fertilization.
    Posada MN; Vlahos NP; Jurema MW; Bracero NJ; Wallach EE; Garcia JE
    Fertil Steril; 2003 Jul; 80(1):103-10. PubMed ID: 12849810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of leuprolide in the treatment of central precocious puberty.
    Lee PA; Page JG
    J Pediatr; 1989 Feb; 114(2):321-4. PubMed ID: 2492599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate.
    Okada H; Inoue Y; Heya T; Ueno H; Ogawa Y; Toguchi H
    Pharm Res; 1991 Jun; 8(6):787-91. PubMed ID: 1905810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leuprolide acetate: pharmaceutical use and delivery potentials.
    Teutonico D; Montanari S; Ponchel G
    Expert Opin Drug Deliv; 2012 Mar; 9(3):343-54. PubMed ID: 22335366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the concurrent LHRH antagonist administration with a LHRH superagonist in rats.
    Kostanski JW; Dani BA; Schrier B; DeLuca PP
    Pharm Res; 2000 Apr; 17(4):445-50. PubMed ID: 10870989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of rat mammary tumors by a potent luteinizing hormone-releasing hormone analogue (leuprolide) administered vaginally.
    Okada H; Sakura Y; Kawaji H; Yashiki T; Mima H
    Cancer Res; 1983 Apr; 43(4):1869-74. PubMed ID: 6403230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term suppression of luteinizing hormone, follicle-stimulating hormone and testosterone by daily administration of leuprolide.
    Glode LM; Smith JA
    J Urol; 1987 Jan; 137(1):57-60. PubMed ID: 3098990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: a randomized clinical trial.
    Penzias AS; Shamma FN; Gutmann JN; Jones EE; DeCherney AH; Lavy G
    Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):739-42. PubMed ID: 1533022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacological evaluation of a lactose-conjugated luteinizing hormone releasing hormone analogue.
    Varasteh Moradi S; Varamini P; Steyn F; Toth I
    Int J Pharm; 2015 Nov; 495(1):106-111. PubMed ID: 26325323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.